Navigation Links
Therapeutic Hypothermia journal launching in spring 2011

New Rochelle, NY, September 13, 2010--Therapeutic Hypothermia and Temperature Management, a new quarterly peer-reviewed journal from Mary Ann Liebert, Inc., publishers, covers all aspects of hypothermia and temperature considerations relevant to this exciting field, including its application in cardiac arrest, spinal cord and traumatic brain injury, stroke, myocardial ischemia, neurogenic fever, emergency medicine, ICU management, anesthesiology, pediatrics, and much more. A full description of the Journal is available at

The Journal is under the editorial leadership of Editor-in-Chief W. Dalton Dietrich, PhD, Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine; European Editor Hans Friberg, MD, PhD, Lund University, Lund, Sweden; Australasian Editor Stephen Bernard, MD, The Alfred Hospital, Victoria, Australia; and a distinguished multidisciplinary editorial board (

The Journal will provide a strong multidisciplinary forum to advance the understanding of therapeutic hypothermia. Novel findings from translational preclinical investigations as well as clinical studies and trials will be featured in original articles, state-of-the-art review articles, provocative roundtable discussions, clinical protocols, and best practices. Therapeutic Hypothermia and Temperature Management will be the journal of record, published in print and online with open access options.

"There is a strong imperative for a dedicated multidisciplinary forum to ensure that research advances are well disseminated, and therapeutic hypothermia is well understood and used effectively to enhance patient outcomes," says Mary Ann Liebert, president of Mary Ann Liebert, Inc.


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
2. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
3. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
4. Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
5. Simple chemical procedure augments therapeutic potential of stem cells
6. New therapeutic target identified for rheumatoid arthritis
7. Mitochondria could be a target for therapeutic strategy for Alzheimers disease patients
8. A novel target for therapeutics against Staph infection
9. Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
10. New potential therapeutic target discovered for genetic disorder -- Barth syndrome
11. Magnetic nanoparticles navigate therapeutic genes through the body
Post Your Comments:
Related Image:
Therapeutic Hypothermia journal launching in spring 2011
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... - BioAmber Inc. (NYSE: BIOA ), a leader in renewable ... Act on Climate Pledge, alongside more than 140 companies from ... Administration to demonstrate an ongoing commitment to climate action and ... Paris climate negotiations. ... . --> BioAmber uses biotechnology to convert ...
(Date:11/30/2015)... , Nov. 30, 2015 Harvard ... ), a biotechnology company developing bioengineered organ implants ... written notification from The NASDAQ Stock Market that ... price requirements. The letter noted that as a ... common stock having exceeded $1.00 per share for ...
(Date:11/30/2015)... GA (PRWEB) , ... November 30, 2015 , ... ... a new globally touring exhibition Jurassic World: The Exhibition, opening in March 2016 ... will embark on a worldwide tour including several North American tour dates. The ...
(Date:11/30/2015)... 30, 2015 TapImmune, Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for ... it will be presenting at the 8 th ... at 2.30 PM PT. Dr. John N. Bonfiglio ... be giving the presentation and will join TapImmune management ...
Breaking Biology Technology: